- Source type
- Trial registry
- Access type
- Publisher
- Publisher
- ClinicalTrials.gov / Lilly Trial Registry
- Added
- 2026-06-19
Trust profile
84
Clinical trial registry
- Publisher type
- Trial registry
- Bias profile
- Moderate
Best used for
- Trial status
- Protocol and endpoint discovery
Weak for
- Unpublished results
- Clinical conclusions
Used in Viral Vitalism
GLP-1s Are Not Just a Weight Loss Story
Roles: Background
Show section-level references
SURMOUNT-MMO: tirzepatide and morbidity/mortality in obesity
Roles: Background
Show section-level references
Claims supported
No reusable evidence claims are currently attached to this source.
Related studies
Related sources
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder
Trial registry for oral semaglutide among adults with AUD.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Does Semaglutide Reduce Alcohol Intake
Trial registry for semaglutide and alcohol intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Effects of Semaglutide on Nicotine Intake
Trial registry for semaglutide and nicotine intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 2 connections
ESSENCE clinical trial registry
ClinicalTrials.gov used across the Viral Vitalism evidence library.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 3 connections
ESSENCE phase 3 trial design for semaglutide in MASH
PubMed used across the Viral Vitalism evidence library.
- Trust score
- 91
- Publisher
- PubMed
- Indexed by
- PubMed
- Access
- Abstract/index
- Usage
- 2 connections
GLP-1R Agonist Treatment for Opioid Use Disorder
Trial registry testing whether semaglutide can reduce illicit opioid use in adults in outpatient OUD treatment.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
